MindMed - Health Technology Insights

MindMed Appoints Matt Wiley as Chief Commercial Officer

March 17, 2025

Mind Medicine Inc., a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the appointment of Matt Wiley as

MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder

December 17, 2024

MindMedicine, MindMed a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that the first patient has been dosed in

Categories

Tag: MindMed

MindMed Appoints Matt Wiley as Chief Commercial Officer

MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder

Share With

Recent Posts

Health Technology Insights: Latest News And Innovations – Roundup 14 November 2025

Welldoc Cements AI Leadership with Dedicated AI Lab and 100+ Clinical Publications

Medulla’s US Entry Signals the Rise of Super-Specialist Health-Tech Advertising

American Nurses Foundation Offers New AI Research Microgrants

Pluto Health and Help.AI Partner To Improve Surgical Outcomes And Lower Cost Of Care

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands